Periñán, María Teresa
Macías-García, Daniel
Jesús, Silvia
Martín-Rodríguez, Juan Francisco
Muñoz-Delgado, Laura
Jimenez-Jaraba, Maria Valle
Buiza-Rueda, Dolores
Bonilla-Toribio, Marta
Adarmes-Gómez, Astrid Daniela
Gómez-Garre, Pilar
Mir, Pablo
Funding for this research was provided by:
Ministerio de Ciencia e Innovación (RTC2019-007150-1)
Instituto de Salud Carlos III (PI14/01823, PI16/01575, PI18/01898, PI19/01576, CM18/00142, CM21/00051)
Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (CVI-02526, CTS-7685)
Consejería de Salud y Bienestar Social, Junta de Andalucía (PI-0471-2013, PE-0210-2018, PI-0459-2018, PE-0186-2019)
Fundación Alicia Koplowitz
Consejería de Salud y Familias, Junta de Andalucía (C-0048-2017, B-0007-2019)
Universidad de Sevilla (USE-18817-A)
Universidad de Sevilla
Article History
Received: 22 March 2022
Revised: 26 July 2022
Accepted: 30 August 2022
First Online: 28 September 2022
Declarations
:
: Periñán MT: none. Macías-García D: has received honoraria from Abbvie and Zambon. Jesús S: has received honoraria from Abbvie, Bial, Merz, UCB, Italfarmaco and Zambon. Martín-Rodriguez JF: none. Muñoz-Delgado L: has received honoraria from Teva. Jiménez-Jaraba MV: none. Buiza-Rueda D: none. Bonilla-Toribio M: none. Adarmes-Gómez AD: has received honoraria from Abbvie and Italfarmaco. Goméz-Garre P: none. Mir P: has received honoraria from Abbott, Allergan, Abbvie. Bial, Britannia, Italfarmaco, Merz, UCB, Teva and Zambon. The authors have no conflict of interest to report.